(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | |||||||||
Cash flow from continuing operating activities | -326.03%-194.64K | -145.76%-1.49M | -110.46%-1.48M | -111.09%-11.44K | 44.41K | -45.69K | -606.76K | -702.5K | 103.16K |
Net income from continuing operations | -784.38%-408.64K | -178.72%-1.55M | -153.09%-1.13M | -251.69%-316.59K | ---61.44K | ---46.21K | ---555.95K | ---444.62K | ---90.02K |
Depreciation and amortization | 1,910.09%11.16K | 2,791.31%14.31K | ---- | ---- | ---- | --555 | --495 | ---- | ---- |
Remuneration paid in stock | --102.97K | --246.58K | --110.95K | ---- | ---- | --0 | --0 | --0 | ---- |
Other non cashItems | ---30.23K | --1.09K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Change In working capital | 371,845.71%130.11K | -296.92%-203.65K | -85.59%-479.54K | -12.25%169.51K | --106.41K | ---35 | ---51.31K | ---258.38K | --193.18K |
-Change in receivables | 698.33%47.54K | -375.09%-254.26K | -144.51%-171.56K | -7,056.66%-72.56K | ---2.19K | ---7.95K | ---53.52K | ---70.17K | --1.04K |
-Change in prepaid assets | --22.33K | 110.19%3.15K | 327.45%19.33K | 4.02%-10.44K | ---5.75K | --0 | ---30.88K | ---8.5K | ---10.87K |
-Change in payables and accrued expense | 661.59%60.24K | 43.44%47.46K | -76.36%-164.44K | -23.09%89.64K | --114.35K | --7.91K | --33.09K | ---93.24K | --116.55K |
Cash from discontinued investing activities | |||||||||
Operating cash flow | -326.03%-194.64K | -145.76%-1.49M | -110.46%-1.48M | -111.09%-11.44K | --44.41K | ---45.69K | ---606.76K | ---702.5K | --103.16K |
Investing cash flow | |||||||||
Cash flow from continuing investing activities | 65.80%-7.43K | -129.19%-25.46K | 56.77%825.5K | -111.57%-641.58K | -187.66K | -21.72K | -11.11K | 526.57K | -303.24K |
Net PPE purchase and sale | 65.80%-7.43K | -129.19%-25.46K | --0 | 13.76%-3.73K | --0 | ---21.72K | ---11.11K | ---6.78K | ---4.33K |
Net other investing changes | ---- | ---- | ---- | -113.39%-637.84K | ---- | ---- | ---- | ---- | ---298.91K |
Cash from discontinued investing activities | |||||||||
Investing cash flow | 65.80%-7.43K | -129.19%-25.46K | 56.77%825.5K | -111.57%-641.58K | ---187.66K | ---21.72K | ---11.11K | --526.57K | ---303.24K |
Financing cash flow | |||||||||
Cash flow from continuing financing activities | -109.75%-19.49K | 387.77%3.19M | 1.09M | 0 | 1.9M | 200K | 654.24K | 0 | 204.15K |
Net issuance payments of debt | ---19.49K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Net common stock issuance | ---- | --1.13M | -48.15%-969.26K | --0 | ---- | ---- | --0 | ---654.24K | --204.15K |
Net other financing activities | ---- | 214.94%2.06M | ---- | ---- | ---- | --200K | --654.24K | ---- | ---- |
Cash from discontinued financing activities | |||||||||
Financing cash flow | -109.75%-19.49K | 387.77%3.19M | --1.09M | --0 | --1.9M | --200K | --654.24K | --0 | --204.15K |
Net cash flow | |||||||||
Beginning cash position | 2,713.77%1.74M | 143.59%61.71K | 446.23%1.3M | 735.34%1.95M | --194.3K | --61.71K | --25.33K | --237.64K | --233.57K |
Current changes in cash | -267.10%-221.56K | 4,503.68%1.67M | 349.11%438.26K | -16,140.78%-653.02K | --1.76M | --132.59K | --36.38K | ---175.93K | --4.07K |
End cash Position | 679.60%1.51M | 2,713.77%1.74M | 2,713.77%1.74M | 446.23%1.3M | --1.95M | --194.3K | --61.71K | --61.71K | --237.64K |
Free cash from | -199.75%-202.06K | -145.46%-1.52M | -108.45%-1.48M | -115.36%-15.18K | --44.41K | ---67.41K | ---617.87K | ---709.28K | --98.83K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.